$ARX

ONeill Francis James sold $1.9M of ARX (indirect holdings)

ONeill Francis James (Co-Founder, Chief U/W Officer) sold 147,000 indirectly-held shares of Accelerant Holdings (ARX) at an average of $13.12 ($13.06–$13.18, $1.93M total) across 2 trades over 2026-06-25 to 2026-06-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · ONeill Francis James
Published Jun 30, 2026, 1:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 30, 2026, 1:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ARX
Neutral
medium confidence
Mentioned
$ARX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARXNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price range, and that it was executed under a pre-arranged 10b5-1 plan; this is primarily sentiment/positioning information rather than a fundamental catalyst.

02

Market read

Traders may monitor ARX for follow-on insider activity, but this specific filing alone is unlikely to drive a durable repricing.

03

What to watch

Indirect holdings and the pre-arranged nature reduce interpretability; without additional context (e.g., total insider activity, subsequent buys), the signal is weak.

Relevance 5/10Novelty 4/10Timing: SEC Form 4 filed 2026-06-29 for sales executed 2026-06-25 to 2026-06-26

Background

The article is an SEC Form 4 insider transaction disclosure for Accelerant Holdings (ARX).

Company-level read

Ticker impact

$ARXNeutralMedium confidence
Context

SEC Form 4 shows co-founder/officer ONeill Francis James sold $1.93M of ARX via a pre-arranged 10b5-1 plan (147,000 shares).

Expected impact

Low near-term impact; any effect is likely sentiment-only and quickly absorbed.

Evidence & confidence

The filing is a disclosed open-market sale under a pre-arranged 10b5-1 plan, with no accompanying company-specific news (guidance, deal, enforcement, or operational update).

Market effects

No sector read-through; this is an issuer-specific insider transaction with no stated operational or regulatory catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations; traders may discount it more than typical insider selling.

Key entities

  • Accelerant Holdings

    Subject of the Form 4 insider transaction disclosure (ARX).

  • ONeill Francis James

    Co-Founder and Chief U/W Officer who sold 147,000 shares indirectly under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ARXHighAI 9/10

Why Is Accelerant Going Private Just One Year After Its IPO?

Accelerant Holdings (ARX) agreed to be acquired by Thoma Bravo in an all-cash deal valuing it at over $4 billion, about a year after its July 2025 IPO. ARX shares rose nearly 44% on Aug. 13, 2026. Class A and B holders receive $20.25 per share. Q2 2026 revenue was $356.9 million (+62.9% YoY) and net income $80 million.

$ARXHighAI 9/10

Accelerant Holdings (ARX) Soars 57% as Buyer Bets Big on Firm

Accelerant Holdings (NYSE:ARX) shares rose about 57% after Thoma Bravo agreed to acquire the company for $4 billion. The offer price is $20.25 per share, a 49% premium to the prior close. ARX said shareholders may receive a 6% annual ticking fee if regulatory approvals delay closing, expected in H1.

$ARXHighAI 9/10

Accelerant Holdings Agrees to Thoma Bravo Take-Private Merger

Accelerant Holdings (ARX) agreed to a take-private merger with Cherry Tree BidCo, affiliated with Thoma Bravo’s Discover Fund V. If completed, ARX shareholders will receive $20.25 per share plus a ticking amount, and ARX will be delisted. The deal needs two-thirds approval and regulatory clearances, with ACP holding about 82% voting rights to support it.